Charles Kummeth
2022
In 2022, Charles Kummeth earned a total compensation of $15.4M as President and CEO at Bio-Techne, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $3,856,735 |
|---|---|
| Option Awards | $5,149,669 |
| Salary | $1,183,000 |
| Stock Awards | $5,149,692 |
| Other | $31,452 |
| Total | $15,370,549 |
Kummeth received $5.1M in stock awards, accounting for 34% of the total pay in 2022.
Kummeth also received $3.9M in non-equity incentive plan, $5.1M in option awards, $1.2M in salary and $31.5K in other compensation.
Rankings
In 2022, Charles Kummeth's compensation ranked 126th out of 5,736 executives tracked by ExecPay. In other words, Kummeth earned more than 97.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 126 out of 5,736 | 98th |
Division Manufacturing | 45 out of 3,125 | 99th |
Major group Chemicals And Allied Products | 11 out of 1,416 | 99th |
Industry group Drugs | 8 out of 1,317 | 99th |
Industry Biological Products, Except Diagnostic Substances | 2 out of 291 | 99th |
Source: SEC filing on September 14, 2022.
Kummeth's colleagues
We found five more compensation records of executives who worked with Charles Kummeth at Bio-Techne in 2022.